0239 GMT - Riverstone Holdings' earnings growth prospects appear intact, based on the recovery of global semiconductor sales and improving market dynamics in the healthcare glove industry, RHB Research's Singapore Research team says in a note. Management expects sales volume growth momentum for its cleanroom gloves to persist in coming quarters, supported by continued orders from U.S. clients, the team notes. Sales volume growth momentum for the Singapore-listed company's healthcare gloves should also be underpinned by more orders from U.S. customers given potential U.S. import tariffs on China, the team adds. RHB raises the stock's target price to S$1.07 from S$1.02 with an unchanged buy rating. Shares are 1.7% higher at S$0.915. (ronnie.harui@wsj.com)
(END) Dow Jones Newswires
November 12, 2024 21:39 ET (02:39 GMT)
Copyright (c) 2024 Dow Jones & Company, Inc.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.